MedPath

Potassium Acetate

Potassium Acetate Injection, USP

Approved
Approval ID

c58f8112-d587-493a-91b7-2b48c80bb7bf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 20, 2021

Manufacturers
FDA

Hospira, Inc.

DUNS: 141588017

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

POTASSIUM ACETATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-3294
Application NumberNDA018896
Product Classification
M
Marketing Category
C73594
G
Generic Name
POTASSIUM ACETATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 20, 2021
FDA Product Classification

INGREDIENTS (3)

POTASSIUM ACETATEActive
Quantity: 196.3 mg in 1 mL
Code: M911911U02
Classification: ACTIB
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Potassium Acetate - FDA Drug Approval Details